| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.0B | $15.9B | $16.1B | $15.9B | $14.5B | $3.5B | $3.5B | $3.6B |
| Cost of Revenue | $7.6B | $7.6B | $9.3B | $9.4B | $8.5B | $2.0B | $2.0B | $2.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.2B | $4.3B | $4.0B | $3.8B | $3.5B | $0.9B | $0.8B | $0.9B |
| Net Income | $3.1B | $3.5B | $3.0B | $3.0B | $2.7B | $0.6B | $0.6B | $0.6B |
| EPS (Basic) | $10.52 | $11.75 | $9.77 | $9.80 | $8.55 | $2.03 | $2.00 | $1.84 |
| EPS (Diluted) | $10.49 | $11.71 | $9.74 | $9.77 | $8.51 | $2.02 | $1.99 | $1.83 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.1B | $15.1B | $15.5B | $15.4B | $16.1B | $15.6B | $15.1B | $14.9B |
| Current Assets | $6.2B | $5.9B | $6.2B | $6.3B | $6.4B | $6.5B | $6.3B | $5.8B |
| Cash & Equivalents | $0.9B | $0.9B | $1.1B | $0.7B | $1.5B | $2.6B | $2.0B | $1.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.1B | $4.3B | $4.7B | $4.5B | $3.5B | $2.6B | $2.2B | $3.5B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $3.3B | $3.5B | $2.3B | $2.6B | $2.8B | $3.0B | $2.8B |
| Investing Cash Flow | $-0.5B | $-0.1B | $-0.4B | $-0.1B | $-1.0B | $-0.2B | $-0.2B | $-0.3B |
| Capital Expenditures | $0.4B | $0.4B | $0.5B | $0.4B | $0.3B | $0.2B | $0.3B | $0.4B |
| Financing Cash Flow | $-2.7B | $-3.2B | $-2.8B | $-3.0B | $-2.6B | $-2.0B | $-2.3B | $-4.0B |